Skip to main content

Table 2 Relationship between basic characteristics and prognosis of patients

From: lncRNA polymorphism affects the prognosis of gastric cancer

Variables

N

MST (M)

Survival rate (%)

HR (95% CI)

P

1-year

3-year

5-year

Gender

 Male

253

29.00

72.67

44.35

37.75

1

0.953

 Female

91

35.00

75.69

48.31

43.71

0.917 (0.667–1.261)

 

Age (years)

 ≦65

120

55.00

84.10

58.86

47.04

1

0.003*

 65-

224

23.00

67.79

38.29

35.17

1.600 (1.179–2.173)

 

Marriage status

 Married

320

31.00

74.30

46.81

40.83

1

0.020*

 Others

24

17.00

62.50

26.17

17.45

1.753 (1.078–0.851)

 

Educational level

 Primary and below

272

28.00

72.38

44.98

38.92

1

0.172

 Junior high

52

28.00

76.70

38.52

33.02

1.151 (0.794–1.667)

 

 Senior high and above

20

73.00

80.00

69.44

62.14

0.560 (0.275–1.139)

 

Occupation

 Farmers

255

28.00

71.32

41.67

36.53

1

0.107

 Others

89

55.00

79.66

56.42

47.37

0.764 (0.548–1.065)

 

Tumor location

 Non-cardia

179

28.00

72.07

44.68

39.76

1

0.594

 Cardia

165

31.00

75.00

46.21

39.01

0.927 (0.701–1.225)

 

TNM stage

 I–III

217

81.00

92.17

66.93

60.16

1

<0.001*

 IV

127

10.00

41.27

8.50

4.64

6.590 (4.889–8.881)

 

Operation

 No

76

8.00

35.53

3.80

1.90

1

<0.001*

 Yes

268

64.00

84.27

57.17

49.92

0.175 (0.129–0.238)

 

Chemotherapy

 No

140

22.00

65.00

40.48

36.49

1

0.036*

 Yes

204

33.00

79.31

48.81

41.23

0.742 (0.561–0.981)

 

Radiotherapy

 No

243

29.00

73.25

44.61

38.47

1

0.528

 Yes

101

33.00

74.00

47.40

41.52

0.905 (0.665–1.233)

 
  1. *P < 0.05. When the MST cannot be calculated, it is replaced by the average survival time